Rfg Advisory, LLC Pa Vmed Inc. Transaction History

Rfg Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.41 - $18.6 $5,535 - $251,100	-13,500 Reduced 11.2%	107,000 $51,000
Q2 2022 Aug 09, 2022	SELL	$0.85 - $1.41 $7,225 - $11,985	-8,500 Reduced 6.59%	120,500 $239,000
Q1 2022 May 11, 2022	BUY	$1.16 - $2.5 $31,667 - $68,250	27,300 Added 26.84%	129,000 $170,000
Q4 2021 Feb 02, 2022	SELL	$2.46 - $8.74 $185,361 - $658,559	-75,350 Reduced 42.56%	101,700 $250,000
Q3 2021 Oct 19, 2021	BUY	$5.1 - $9.39 $449,309 - $827,259	88,100 Added 99.04%	177,050 $1.51 Million
Q2 2021 Jul 29, 2021	BUY	$3.95 - $6.88 $67,742 - $117,992	17,150 Added 23.89%	88,950 $569,000
Q1 2021 Apr 19, 2021	BUY	$2.01 - $5.55 $144,317 - $398,490	71,800 New	71,800 $319,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rfg Advisory, LLC with notifications on news.